期刊文献+

RP-HPLC法测定加替沙星血药浓度 被引量:10

Determination of Gatifloxacin Concentration in Human Plasma by HPLC
暂未订购
导出
摘要 目的 :建立高效液相色谱法测定血浆中加替沙星浓度。方法 :血浆用二氯甲烷提取 ,色谱柱为ZorbaxC18(4.6mm×2 5 0mm) ,流动相为 0 .0 1mol·L-1磷酸二氢钾 甲醇 三乙胺 (6 5∶34.8∶0 .2 ) ,检测波长 2 92nm ,流速 1.0ml·min-1,以司帕沙星为内标。结果 :加替沙星浓度线性范围 0 .0 1~ 5 μg·ml-1,最低检测浓度 0 .0 1μg·ml-1,绝对回收率为 85 .1% ,相对回收率为10 0 .6 %。日内 ,日间RSD分别为 3.0 %和 3.7%。结论 :该方法适用于人体药物动力学研究。 Objective: To determine the gatifloxocin concentration in human plasma by HPLC.Method: Gatifloxacin was extracted from plasma with dichloromethane. It was chromatographed on an Zorbax ODS column with spafloxacin as internal standard. The mobile phase consisted of 0.01 mol·L -1 KH 2PO 4 methanol triehylamine (65∶ 34.8 ∶ 0.2 ) adjusted to pH 3.0 with orthophosphoric acid. The flow rate was 1.0 ml·min -1 and the detecting wavelength was at 292 nm.Result: The calibration curve was linear from 0.01 to 5.0 μg·ml -1 . The detecting limit of gatifloxacin was 0.01 μg·ml -1 . The absolute and relative recoveries of gatifloxacin in plasma were 85.1% and 100.6% , respectively. RSD within day and between day were 3.0% and 3.7% , respectively.Conclusion: The method can be used to investigate the pharmacokinetics of gatifloxacin in human plasma.
出处 《中国药师》 CAS 2004年第9期715-716,共2页 China Pharmacist
关键词 加替沙星 血药浓度 HPLC Gatiflaxacin plasma drug concentration RP-HPLC HPLC
  • 相关文献

参考文献3

  • 1朱曼,王睿,等.人体血浆及尿液中甲磺酸加替沙星浓度的HPLC测定法[J].药物分析杂志,2003,23(1):53-56. 被引量:29
  • 2Christoph KN, Michaela S, Martina KS et al. Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate and sperm cells after single oral administration of 400mg to volunteers[J]. Antimicrob Agents chemot
  • 3Silke L, Susanne Z, Margot R, et al. Pharmacokinetics of gatifloxacin and interaction with an antacid containing Aluminum and Magnesium[J]. Antimicrob Agents chemother, 1999,43(5):1067-1071

二级参考文献7

  • 1Lubasch A, Keller I, Borner K,et al. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers.J Anthmicrob Agents Chemother,2000,44(10) :2600
  • 2Naber CK, Steghafner M, Kingig-Schippers M, et al. Concentrations of gatifloxacin mesylate in plasma and urine and penetrition into prostatic and seminal fluid,ejaculate,and sperm cells after single oral administrations of 400 milligrams to volunteers. J Anthmicrob Agents Chemother,2001,45 (1) :293
  • 3Nakashima M, Uematsu T, Kosuge K,et al. Single - and multiple -dose pharmacokinetics of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone, in humans. J Antimicrob Agents Chemother, 1995, 39(12) :2635
  • 4Stahlberg H J, Gohler K, Guillane M,et al. Effects of gatifloxacin mesylate ( GTFX ) on the pharmacokinetics of theophyline in heathly young volunteers [ abstract]. J Antimicrob Agents Chemther, 1999,44(suppl A) :136
  • 5Perry CM, Balfour JAB, Lamb HM. Gatifloxacin. Drugs, 1999, 58(4) :683
  • 6Hosaka M,Yasue T,Fukuda H,et al. In vitro and in vivo antibacterial activities of AM - 1155, a new 6 - fluoro - 8 - methoxy quinolone. J Antimicrob Agents Chemother, 1992,36 ( l0 ) :2108
  • 7孙涛,宋坤改,林赴田.盐酸加替沙星的药代动力学研究[J].中国新药杂志,2000,9(11):758-761. 被引量:35

共引文献28

同被引文献61

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部